---
title: "ROADSTER 3 provides key evidence that ‘goes beyond registry data’ on TCAR-related stroke rates"
date: "2025-02-05T17:43:26.000Z"
publishedDate: "5 février 2025"
summary: "Thirty-day results from the ROADSTER 3 study have demonstrated that transcarotid artery revascularisation (TCAR) is a safe and effective approach in patients who are deemed to be ‘standard risk’ for experiencing adverse events related to carotid endarterectomy (CEA). These findings were presented at the 2024 Vascular InterVentional Advances (VIVA) conference (3–6 November, Las Vegas, USA) [&#8230;] The post ROADSTER 3 provides key evidence that ‘goes beyond registry data’ on TCAR-related stroke rates appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/roadster-3-provides-key-evidence-that-goes-beyond-registry-data-on-tcar-related-stroke-rates/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-02-05-roadster-3-provides-key-evidence-that-goes-beyond-registry-data-on-tcar-related-stroke-rates"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2024/01/stroke-brain-blood-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/roadster-3-provides-key-evidence-that-goes-beyond-registry-data-on-tcar-related-stroke-rates/"
---

![ROADSTER 3 provides key evidence that ‘goes beyond registry data’ on TCAR-related stroke rates](https://vascularnews.com/wp-content/uploads/sites/7/2024/01/stroke-brain-blood-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/roadster-3-provides-key-evidence-that-goes-beyond-registry-data-on-tcar-related-stroke-rates/*

## L’essentiel

Thirty-day results from the ROADSTER 3 study have demonstrated that transcarotid artery revascularisation (TCAR) is a safe and effective approach in patients who are deemed to be ‘standard risk’ for experiencing adverse events related to carotid endarterectomy (CEA). These findings were presented at the 2024 Vascular InterVentional Advances (VIVA) conference (3–6 November, Las Vegas, USA) [&#8230;] The post ROADSTER 3 provides key evidence that ‘goes beyond registry data’ on TCAR-related stroke rates appeared first on Vascular News .

## Lien source

https://vascularnews.com/roadster-3-provides-key-evidence-that-goes-beyond-registry-data-on-tcar-related-stroke-rates/
